ArticleVeterinary research communications2025
Real-time PCR versus culture of bronchoalveolar lavage fluid for detecting Bordetella bronchiseptica in dogs with persistent lower respiratory signs: a retrospective study of 23 cases.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bordetella bronchiseptica (Bb) is a frequent pathogen in dogs and a component of the Canine Infectious Respiratory Disease Complex (CIRDC). However, it can also be detected in the lower respiratory tract of healthy animals, complicating its interpretation in clinical settings. This retrospective study compared the detection of Bb in bronchoalveolar lavage fluid (BALF) samples using real-time PCR versus bacterial culture in dogs referred for persistent lower respiratory tract signs to a referral hospital in Spain between 2018 and 2024. A total of 143 BALF samples were analyzed; 23 dogs tested positive for Bb by at least one method and were included in the clinical analysis. Real-time PCR identified Bb in 16.1% (23/143) of cases (95% CI:10.4-23.1%). Among these, 40% (9/23) had negative culture results. Co-infections with Mycoplasma spp. or Mycoplasma cynos were detected in 30% (7/23) of cases, and 26% (6/23) had positive cultures for other bacteria. Most dogs (91% (21/23)) had received antibiotics prior to BALF collection. The median time to clinical remission was 30 days. While real-time PCR showed a higher detection rate than culture, its results must be interpreted cautiously. PCR may amplify DNA from non-viable organisms or colonizers, and thus does not confirm active infection. Our findings underscore the need to integrate molecular, microbiological, and clinical data to reach an accurate diagnosis and avoid inappropriate antimicrobial use. Combining PCR and culture may enhance diagnostic accuracy, as culture alone would have failed to detect Bb in 40% of PCR positive dogs.
Indexed as
Identifiers
40663178What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.